Shelton confirms the power of talk in the specific case of the 1994 debate on comprehensive health care reform and beyond. He provides a context rich with detail concerning health care and health care reform in America and a social scientific examination of specific discourse factors that includes narratives, naming, and medical metaphors. Shelton's assessment of the debate reveals that opposition discourse was much more directly impacted and broader in scope. This is followed by a rhetorical analysis that extends the genre of crisis rhetoric. Shelton's rhetorical analysis reveals that the virtual crisis of big government both subsumed and overwhelmed the actual health care crisis. Such an assessment--including an ethical analysis of the 1994 floor debate and detailed consideration of the social existence of hatred for government--produces a host of research and scholarly implications. A thoughtful analysis that will be of value to scholars and researchers in political communication and public policy.

This book offers a comprehensive study of the complexities of newborn survival in resource-poor regions, using the state of Bihar (India) as a case study. It provides important lessons for other low-performing countries, in similar socioeconomic contexts, where newborn survival is a major challenge. The volume opens with a brief account of the trends and regional variations in neonatal mortality. The empirical verification of socio-cultural, economic and health system barriers and the state interventions that affect newborn survival are subsequently explored. Innovative strategies are then proposed to scale up maternal newborn and child health (MNCH) services and improve neonatal health outcomes. Addressing this issue through appropriate policy action is essential to achieving Sustainable Development Goal-3, "Good Health and Well-being". This book will therefore appeal to public health scholars, professionals and policymakers interested in improving outcomes in low-income regions.

The last five years saw a significant return of epidemic infectious disease, culminating in COVID-19. In our new post-COVID-19 world, how do we prevent future illnesses by expanding scientific and vaccine diplomacy and cooperation, especially to combat the problems that humans have brought on ourselves? Modern diseases and viruses have been spurred anew by war and conflict as well as shifting poverty, urbanization, climate change, and a new troubling anti-science/anti-vaccination outlook. From such twenty-first-century forces, we have seen declines in previous global health gains, with sharp increases in vaccine-preventable and neglected diseases on the Arabian Peninsula, in Venezuela, in parts of Africa, and even on the Gulf Coast of the United States. In Preventing the Next Pandemic, international vaccine scientist and tropical disease and coronavirus expert Peter J. Hotez, MD, PhD, argues that we can-and must-rely on vaccine diplomacy to address this new world order in disease and global health. Detailing his years in the lab developing new vaccines, Hotez also recounts his travels around the world to shape vaccine partnerships with people in countries both rich and poor in an attempt to head off major health problems. Building on the legacy of Dr. Albert Sabin, who developed the oral polio vaccine with Soviet scientists at the height of the Cold War, he explains how he is still working to refresh and redirect vaccine diplomacy toward neglected and newly emerging diseases. Hotez reveals how-during his Obama-era tenure as the US Science Envoy for the Middle East and North Africa, which coincided with both the rise in these geopolitical forces and climate change-he witnessed tropical infectious diseases and established vaccine partnerships that may still combat them up close. He explores why, since 2015, we've seen the decline of global cooperation and cohesion, to the detriment of those programs that are meant to benefit the most vulnerable people in the world. Unfortunately, Hotez asserts, these negative global events kick off a never-ending loop. Problems in a country may lead to disease outbreaks, but those outbreaks can lead to further problems-such as the impact of coronavirus on China's society and economy, which has been felt around the globe. Zeroing in on the sociopolitical and environmental factors that drive our most controversial and pressing global health concerns, Hotez proposes historically proven methods to soothe fraught international relations while preparing us for a safer, healthier future. He hammers home the importance of public engagement to communicate the urgency of embracing science during troubled times. Touching on a range of disease, from leishmaniasis, schistosomiasis, and Middle East Respiratory Syndrome (MERS) to COVID-19, Preventing the Next Pandemic has always been a timely goal, but it will be even more important in a COVID and post-COVID world.

The construct quality of life (QoL), since the 1980s, when it was introduced, is being used mainly in the context of health problems. Areas of one s life that contribute to QoL are good physical and mental health, efficient cognitive functioning, social support, being able to meet the requirements of professional life, positive emotions, etc (Power, 2003). Work on subjective well-being (SWB), on the other hand, was developed in the context of healthy everyday life; it also has a history of more than 30 years. During this 30-year period factors that have an impact on SWB, such as SES, gender, health, age, and religiosity have been identified (Diener, 2000). A third independent line of research pertains to what has been called Positive Psychology (Seligman & Csikszentmihalyi, 2000), that is, an emphasis on human strengths, such as optimism, hope, wisdom, positive emotions, resilience, etc., which contribute to positive functioning in life.

Recently, SWB has been associated to human strengths and to the movement of positive psychology but this did not happen for QoL, possibly because of its emphasis on people with health problems. However, QoL can be conceived of as a generic term that pertains to all people, healthy or not. In this sense, it is closely related to SWB defined as happiness (Diener, 2000). Also, QoL encompasses positive emotions that go beyond happiness and has the advantage that it can be applied to many different domains of life such as interpersonal relations, health-related situations, and professional and educational strivings. Moreover, the mechanism(s) that underpin QoL and SWB can be studied in relation to people s goals and strengths of character, that is, from a positive psychological perspective. Such a perspective can reveal the specificities of quality in the various domains of life and, specifically, the positive emotions and strengths that contribute to a happier, healthier, and more successful life, even in face of adversity.

Therefore, despite the differences among the three theoretical traditions, namely QoL, SWB, and positive psychology, it is possible to find the common ground they share and each of them can benefit from notions developed in the others. The aim of the present book is to bring together these three traditions, show the interactions of variables emphasized by them, and give an integrative perspective from the positive psychology point of view. It also aims to extend the range of life situations in which one can look for quality and which go beyond the traditional emphasis of QoL on health problems. Thus, the content of the proposed book covers different age populations (from children to older adults), healthy and people facing health problems as well as people facing problems in their interpersonal lives or in their pursuits. It also discusses factors that contribute to marital satisfaction, well being in the school context, and things that people value and cherish. The chapters refer to notions such as happiness, interest, resilience, wisdom, hope, altruism, optimism, and spirituality/religiosity that represent unique human strengths. Finally, it emphasizes the role of goals and motivation that connect SWB with self-regulation and managing of one s life priorities.

To conclude, the chapters included in the proposed edited book aim at bringing to the fore new theoretical developments and research on QoL, SWB, and positive psychology that bridges previously distinct theoretical traditions. The proposed book covers a broad range of topics, addresses different theoretical interests and paves the way for a more integrative approach. Finally, it brings together an international set of authors, from USA, Europe, Australia, and Asia. "

Tuberculosis is one of the world's deadliest infectious diseases, killing nearly two million people every year-more now than at any other time in history. While the developed world has nearly forgotten about TB, it continues to wreak havoc across much of the globe. In this interdisciplinary study of global efforts to control TB, Christian McMillen examines the disease's remarkable staying power by offering a probing look at key locations, developments, ideas, and medical successes and failures since 1900. He explores TB and race in east Africa, in South Africa, and on Native American reservations in the first half of the twentieth century, investigates the unsuccessful search for a vaccine, uncovers the origins of drug-resistant tuberculosis in Kenya and elsewhere in the decades following World War II, and details the tragic story of the resurgence of TB in the era of HIV/AIDS. Discovering Tuberculosis explains why controlling TB has been, and continues to be, so difficult.

This new edition is a complete guide to vaccines and immunisation for paediatricians and trainees. Presented in question and answer format, the text begins with discussion on vaccine immunology and epidemiology, schedules, storage, vaccine delivery systems, and safety. The following sections cover vaccines for many different diseases and infections including hepatitis, measles, influenza, HIV, HPV, and many more. The third edition has been fully revised to provide the latest advances in the field. New topics have been added to this edition such as Coronavirus vaccines, vaccine-preventable diseases (VPD) surveillance, Cytomegalovirus (CMV) vaccine, and enterovirus vaccines. With contributions from experts in the field, this practical book helps answer all the questions practitioners may face in real-life, day to day practice. Key points Practical guide to vaccines and immunisation for paediatricians and trainees Fully revised, third edition featuring latest advances and many new topics Presented in question and answer format Previous edition (9789351521471) published in 2015

Who gets diabetes and why? An in‑depth examination of diabetes in the context of race, public health, class, and heredity.

Who is considered most at risk for diabetes, and why? In this thorough, engaging book, historian Arleen Tuchman examines and critiques how these questions have been answered by both the public and medical communities for over a century in the United States.

Beginning in the late nineteenth century, Tuchman describes how at different times Jews, middle‑class whites, American Indians, African Americans, and Hispanic Americans have been labeled most at risk for developing diabetes, and that such claims have reflected and perpetuated troubling assumptions about race, ethnicity, and class. She describes how diabetes underwent a mid-century transformation in the public’s eye from being a disease of wealth and “civilization” to one of poverty and “primitive” populations.

In tracing this cultural history, Tuchman argues that shifting understandings of diabetes reveal just as much about scientific and medical beliefs as they do about the cultural, racial, and economic milieus of their time.

It's natural... It's unsightly... It's normal... It's dangerous. To breastfeed or not? For millions of women around the world, this personal decision is influenced by numerous social, cultural, and health factors. Infant Feeding Practices is the first book to delve into these factors from a global perspective, revealing striking similarities and differences from country to country. Dispatches from Asia, Australia, Africa, the U.K., and the U.S. explore as wide a gamut of salient issues affecting feeding practices as traditional beliefs about colostrums, "breast is best" campaigns, partner attitudes, workplace culture, direct government intervention, and the pressure to be a "good mother." Throughout these informative pages, women are seen balancing innovation and tradition to nurture healthy, thriving babies. A sampling of topics covered: * Policy versus practice in infant feeding. * Infant feeding in the age of AIDS. * Managing the lactating body: the view from the U.S. * Motherhood, work, and feeding. * The effects of migration on infant feeding. * From breastfeeding tradition to optimal breastfeeding practice. Infant Feeding Practices is a first-of-its-kind resource for researchers and practioners in maternal and child health, public health, global health, and cultural anthropology seeking empirical findings and culturally diverse information on this sensitive issue.

The notion that contaminated environments in hospital settings significantly contribute to the risk of an individual acquiring an infection while hospitalized is continuously gaining recognition by the medical community. There is a clear correlation between the environmental bioburden present in a clinical setting and the risk of patients acquiring an infection. Thus using self-disinfecting surfaces can be a very important adjunct in the fight against nosocomial pathogens.

This book reviews the increasing evidence that contaminated non-intrusive soft and hard surfaces located in the clinical surroundings are a source of nosocomial pathogens and focuses on the utility of copper containing materials in reducing bioburden and fighting hospital acquired infections. It also reviews other biocidal surface alternatives and the economics of using biocidal surfaces in a hospital environment. Finally, it discusses the pros and cons of existent disinfection modalities other than biocidal surfaces.

A behind-the-scenes look inside three key trials involving Monsanto's weed killer Roundup, cancer, and the search for justice—written by an expert witness medical oncologist who lived it all. For years, Monsanto declared that their product Roundup, the world's most widely used weed killer, was safe. But that all changed in 2015, when the International Agency for Research on Cancer (IARC) analyzed data from scientific studies and concluded that glyphosate, the active ingredient in Roundup, is probably carcinogenic. The Environmental Protection Agency (EPA) disagreed, other regulatory agencies got involved, and scientists clamored to understand the link between glyphosate and cancer. Toxic Exposure tells the true story of numerous patients who developed non-Hodgkin lymphoma, a form of cancer, after using Roundup and their ensuing trials against Monsanto (now owned by Bayer, one of the largest agrochemical companies in the world). Written by Chadi Nabhan, MD, MBA, a cancer specialist, this is the only book written by an expert physician witness who testified in the first three trials against Monsanto. Dr. Nabhan takes the reader behind the scenes of these pivotal trials, explaining key features of the cases, including how Monsanto downplayed the IARC's scientific conclusions, may have worked to change how the EPA classified glyphosate, and conducted extensive PR campaigns designed to minimize the public's perception of the negative health effects of its product. He also provides details about the other expert witnesses who reviewed the evidence, analyzed the science, and stood up to this agricultural behemoth in the courtroom. Dr. Nabhan tells the inside story of corporate influence, courtroom drama, legal discourse, monumental verdicts, and the ensuing media frenzy surrounding this massive uncovering of the truth and the years of scientific and legal work that led up to it.

From the Nordic countries (Denmark, Norway, Sweden and Finland) comes an exciting source of theoretical approaches, epidemiological findings, and real-life examples regarding the therapeutic and health-enhancing effects of music. Experts across fields including psychology, neurology, music therapy, medicine, and public health review research on the benefits of music in relieving physiological, psychological, and socioemotional dysfunction. Chapters link musical experiences (listening and performing, as well as involvement in movement, dance, and theatre) to a wide range of clinical and non-clinical objectives such as preventing isolation, regulating mood, reducing stress and its symptoms, and treating dementia. And the book's section on innovative music-based interventions illustrates opportunities for incorporating musical activities into public health programs. Among the topics covered are: * Associations between the use of music, cultural participation and health-related outcomes in adult Scandinavian populations * Music practice and emotion handling * How music translates itself biologically in the body * Music as a forum for social-emotional health * Participation and partnership as core concepts in music and public health * Music therapy as health promotion for mothers and children at a public health clinic Music and Public Health will gain interested readers among researchers, teachers, students, and clinicians in the fields of music education and therapy, as well as researchers and students of public health who are interested in the influence of culture and the arts. The book also will be relevant to administrators in public health services.

In just under three decades, the world has witnessed an enormous rise in obesity with a parallel growth in cardiometabolic disease risk factors characterized by insulin resistance, dyslipidemia, and hypertension, together known as the metabolic syndrome - conditions previously unheard of in children and adolescents. During this time, we have little knowledge of the global and cumulative detrimental health effects of childhood obesity. As obese children age, not only will their health be negatively affected, but infertility and pregnancy complications associated with the metabolic syndrome will affect generations to come. The work force will undoubtedly be affected because of increased sick days and decreased work productivity. Identifying children and adolescents at the earliest stages of chronic disease onset should be the goal of clinical practice, yet there is no clear guidance for defining the risk of metabolic syndrome or appropriate risk-factor thresholds in these groups. If children are identified early in the disease process, lifestyle and clinical interventions can be instituted when they are potentially more effective. Pediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues approaches the pediatric metabolic syndrome by elucidating its effects on specific organ systems and by considering the problem through understanding the social, psychological and economic consequences of it. The Editors have recruited an invited group of esteemed experts in the field to provide the most timely and informative approaches on how to deal with this health crisis. Through educating our practitioners, our future researchers, our health and community organizations, our legislators and our families and children, we have the best chance at improving the health trajectory of the next generation.

This two-volume work covers the molecular and cell biology, genetics and evolution of influenza viruses, the pathogenesis of infection, resultant host innate and adaptive immune response, prevention of infection through vaccination and approaches to the therapeutic control of infection.. Experts at the forefront of these areas provide critical assessments with regard to influenza virology, immunology, cell and molecular biology, and pathogenesis. Volume I provides overviews of the latest findings on molecular determinants of viral pathogenicity, virus entry and cell tropism, pandemic risk assessment, transmission and pathogenesis in animal species, viral evolution, ecology and antigenic variation, while Volume II focuses on the role of innate and adaptive immunity in pathogenesis, development of vaccines and antivirals.

As researchers unravelled the mysteries of these new viruses, drug companies navigated new antiviral therapies designed to treat and prevent influenza through clinical trials.The continual development of new antivirals and control measures underscores not only the significance of influenza, but highlights options for the control of influenza

As public accountability has increased and resources have become scarcer, public health, like clinical medicine, has been forced to re-examine the benefits and costs of its activities. Decision and economic analysis are basic tools in carrying out that mission. These methods have become standard practice in clinical medicine and health services research. This book, now in its second edition, was written in an effort to apply and adapt that experience to public health situations.

The book was originally written to introduce Centers for Disease Control and Prevention staff to the concepts of decision and economic analysis, to provide guidance on methods to maximize comparability of studios, and to provide access to frequently used reference information. It has been adapted to meet the needs of scientists and managers in state and local health departments and managed care organizations as well as students in schools of public health and clinicians for an introductory text - a text that shows how these methods can be applied in population-based practice, to facilitate better comparability of studies, and to solidify understanding of the scientific basis for use of these tools in decision making. Decision makers will learn how these studies are conducted so they can be critical consumers, understanding the strengths and limitions, and apply findings to policy and practice.

The second edition updates and expands upon the standard methodology for condcuting prevention effectiveness analyses. Each chapter has been revised or re-written. The chapters on measuring effectiveness, decision analysis, and making information useful for decision makers as well as several appendices are entirely new.

Geographical Information Systems (GIS) have developed rapidly in recent years and now provide powerful tools for the capture, manipulation, integration, interrogation, modelling, analysis and visualisation of data - tools that are already used for policy support in a wide range of areas at almost all geographic and administrative levels. This holds especially for emergency preparedness and health risk reduction, which are all essentially spatial problems. To date, however, many initiatives have remained disconnected and uncoordinated, leading to less powerful, less compatible and less widely implemented systems than might otherwise have been the case.
The important matters discussed here include the probabilistic nature of most environmental hazards and the semi-random factors that influence interactions between these and human exposures; the effects of temporal and spatial scales on hazard assessment and imputed risk; the effects of measurement error in risk estimation and the stratification of risks and their impacts according to socioeconomic characteristics; and the quantification of socioeconomic differences in vulnerability and susceptibility to environmental hazards.
GIS are powerful analytical tools in their own right, but what is needed is much more effective communication between the many disciplines, professions and stakeholders concerned - something which this book helps to achieve.

This is a critical assessment of breakthrough biosensor technologies that will allow for the rapid identification of biological threat agents in the environment and human population. The book provides a comprehensive overview of the current state of biological weapons threat, and reviews biosensor technologies including detection platforms, networked alarm-type biodetector systems, implementation strategies, electro-optical and electrochemical biosensors.

Mass immunization is the blitzkrieg of vaccination practice. It serves to rapidly protect populations, both because of the high coverage achieved and because of the herd immunity thereby induced. However, as in war, mass immunization campaigns must be conducted intelligently, with careful strategy and strong attention to logistics of supply and deployment. If conducted badly, mass immunization may fail or even be counter-productive. In this volume, some of the most successful practitioners of mass im- nization tell us about its art and science. David Heymann and Bruce Aylward of WHO begin the book with a theoretical and practical overview of mass immunization. Michael Lane, who participated in the successful effort to eradicate smallpox relates how this was done using mass vaccination and other strategies. Application of mass immunization by the US military is c- ered by John Grabenstein and Remington Nevin, who have a large experience in these matters. Karen Noakes and David Salisbury recount the striking s- cesses of mass immunization in the United Kingdom. The global control of the clostridia that produce diphtheria toxin is described by Charles Vitek. Hepa- tis A is decreasing dramatically under the impact of large-scale vaccination, as Francis Andre illustrates. The French experience with Hepatitis B vac- nation has been mixed, and Francois Denis and Daniel Levy-Bruhl explain the circumstances. In?uenza vaccination is an annual example of large-scale campaigns, the complexity of which is recounted by Benjamin Schwartz and Pascale Wortley.